Pictet-Biotech HR EUR

Register to Unlock Ratings
Performance History30/04/2024
Growth of 1,000 (GBP) Advanced Graph
Pictet-Biotech HR EUR
Fund31.9-15.9-14.17.5-6.6
+/-Cat-----
+/-B’mrk-----
 
Key Stats
NAV
06/05/2024
 EUR 467.54
Day Change -1.40%
Morningstar Category™ Other Equity
ISIN LU0190162189
Fund Size (Mil)
03/05/2024
 USD 1578.42
Share Class Size (Mil)
03/05/2024
 EUR 96.29
Max Initial Charge 3.00%
Ongoing Charge
18/04/2024
  2.75%
Investment Objective: Pictet-Biotech HR EUR
This Compartment applies a capital growth strategy by investing at least two-thirds of its total assets/total wealth in equities or similar securities issued by biopharmaceutical companies throughout the world (including emerging countries). However, in light of the particularly innovative nature of the pharmaceutical industry in North America and Western Europe, the vast majority of investments will be made in these regions. To capitalise on particularly innovative projects in the pharmaceuticals field, the Biotech Compartment may invest up to 10% of its net assets in Private Equity and/or unlisted securities.
Returns
Trailing Returns (GBP)06/05/2024
YTD-1.93
3 Years Annualised-4.85
5 Years Annualised2.24
10 Years Annualised2.97
12 Month Yield 0.00
Management
Manager Name
Start Date
Tazio Storni
26/05/2016
Marco Minonne
01/06/2020
Click here to see others
Inception Date
30/06/2004
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
MSCI ACWI NR EUR-
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Pictet-Biotech HR EUR31/03/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock98.900.0098.90
Bond0.040.10-0.06
Property0.000.000.00
Cash1.650.491.16
Other0.000.000.00
Top 5 Regions%
United States91.96
United Kingdom2.11
Eurozone2.06
Europe - ex Euro2.01
Canada1.85
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Moderna IncHealthcareHealthcare4.98
argenx SE ADRHealthcareHealthcare4.25
Viking Therapeutics IncHealthcareHealthcare3.94
Biomarin Pharmaceutical IncHealthcareHealthcare3.86
Blueprint Medicines CorpHealthcareHealthcare3.82
Pictet-Biotech HR EUR

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures